WebDisclosure WebDisclosure
Basculer en Français
10163 Companies
208794 Keywords
138911 Articles
110675 Press releases
Headlines Articles Press releases Neuro20 Technologies Remove
  1. Home
  2. Companies
  3. Neuro20 Technologies
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/27/2024 at 16:05, 1 year 9 months ago

    Neuro20 Sparks Hope for Long COVID Recovery

    Long Covid Clinical Trials Neuro20 FDA-approved Device Patient Improvement
  • BRIEF

    published on 06/27/2024 at 16:05, 1 year 9 months ago

    Neuro20 suscite l’espoir d’une longue guérison suite au COVID

    Essais Cliniques Longue COVID Neuro20 Appareil Approuvé Par La FDA Amélioration Des Patients
  • PRESS RELEASE

    published on 06/27/2024 at 16:00, 1 year 9 months ago

    Neuro20 Sparks Hope for Long COVID Recovery

    Neuro20 Technologies Corp. releases White Paper on patient improvements and potential mechanisms for Long COVID, showcasing the efficacy of their FDA-cleared wearable muscle stimulation device
    Wearable Device Long Covid White Paper Neuro20 Technologies Corp. FDA Cleared
    Logo of Neuro20 Technologies
Accesswire
  • Published on 04/07/2026 at 00:02, 4 hours 44 minutes ago

    Evergold Announces Closing of $5.4 Million Non-Brokered Private Placement

  • Published on 04/06/2026 at 22:25, 6 hours 21 minutes ago

    NioCorp Reports Voting Results from Its 2025 Annual General Meeting

  • Published on 04/06/2026 at 15:15, 13 hours 31 minutes ago

    Datavault AI CEO Nathaniel T. Bradley to Deliver Flagship Keynotes on Breakthrough RWA Tokenization at CONV3RGENCE London and AssetRush × Zurich 2026

  • Published on 04/06/2026 at 14:55, 13 hours 51 minutes ago

    Hillcrest Closes Shares for Debt Offering

  • Published on 04/06/2026 at 14:02, 14 hours 44 minutes ago

    Black Iron annonce un placement privé d’unités pour un produit brut pouvant atteindre 1,7 million de dollars américains

View all ACCESSWIRE
EQS Group
  • Published on 04/06/2026 at 19:00, 9 hours 46 minutes ago

    PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 30 MARS 2026 au 03 AVRIL 2026

  • Published on 04/06/2026 at 15:50, 12 hours 56 minutes ago

    Mesabi Metallics Secures $150 Million from Macquarie Group

  • Published on 04/06/2026 at 15:24, 13 hours 22 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Schroders plc

  • Published on 04/06/2026 at 15:23, 13 hours 23 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The

  • Published on 04/06/2026 at 15:21, 13 hours 25 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Beazley plc

View all EQS
Les Echos
  • Published on 04/06/2026 at 15:00, 13 hours 46 minutes ago

    FinanceWire Introduces Certidox to Enable Verifiable Press Releases as Fake Content Becomes Indistinguishable from Reality

  • Published on 04/06/2026 at 15:00, 13 hours 46 minutes ago

    FinanceWire intègre Certidox pour permettre la vérification des communiqués de presse, alors que les contenus falsifiés deviennent impossibles à distinguer de la réalité

  • Published on 04/03/2026 at 18:46, 3 days 10 hours ago

    Disclosure of Share Capital and Voting Rights as of March 31, 2026

  • Published on 04/03/2026 at 18:46, 3 days 10 hours ago

    Déclaration du nombre d’actions et droits de vote au 31 mars 2026

  • Published on 04/03/2026 at 18:01, 3 days 10 hours ago

    ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy